Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0034 | 0.9 |